---
layout: minimal-medicine
nav_exclude: true
title: Lorlatinib
---

# Lorlatinib

**Generic Name:** Lorlatinib

**Usage:** Lorlatinib is a medication used to treat certain types of non-small cell lung cancer (NSCLC). Specifically, it's used in patients with:

* **ALK-positive NSCLC:** This means the cancer cells have a specific genetic abnormality (ALK rearrangement) that drives their growth.  Lorlatinib is often used after treatment with other ALK inhibitors has stopped working (acquired resistance).
* **ROS1-positive NSCLC:** Similar to ALK-positive NSCLC, this refers to cancers with a ROS1 gene rearrangement. Lorlatinib may be used as a first-line treatment or after other treatments have failed.

It's important to note that lorlatinib is a prescription medication and should only be used under the guidance of an oncologist or other qualified healthcare professional. The specific usage and dosage will depend on the individual patient's condition and medical history.

**Side Effects:** Lorlatinib can cause a range of side effects, some common and some serious.  The frequency and severity of these side effects vary from person to person.  Some common side effects include:

* **Brain-related side effects:** These are common and can be serious. They may include dizziness, headache, confusion, drowsiness, and vision changes.
* **Gastrointestinal problems:** Nausea, vomiting, diarrhea, constipation, and loss of appetite.
* **Elevated liver enzymes:**  Liver function tests should be monitored regularly.
* **Elevated cholesterol and triglycerides:** Lipid levels should be checked regularly.
* **Fatigue and weakness:** Feeling tired and lacking energy.
* **Skin rash:**  Itching or skin irritation.
* **Weight gain:**  Significant weight increase is possible.
* **Interstitial lung disease (ILD):** A serious lung condition requiring immediate medical attention.  This is a particularly important side effect to watch for.


**This is not an exhaustive list.**  Always consult your doctor or pharmacist about any potential side effects and report any concerning symptoms immediately.

**How it Works:** Lorlatinib is a type of tyrosine kinase inhibitor (TKI).  It works by blocking the activity of ALK and ROS1 enzymes.  These enzymes are involved in the growth and spread of certain cancer cells. By inhibiting these enzymes, lorlatinib helps to stop or slow the growth of cancer.


**FAQs:**

* **Q: Is Lorlatinib a first-line treatment option?** A: While it can be used as a first-line treatment for some patients with ROS1-positive NSCLC, it's more commonly used after other ALK/ROS1 inhibitors have stopped working in ALK-positive or ROS1-positive NSCLC.
* **Q: How is Lorlatinib administered?** A: Lorlatinib is taken orally as a tablet.
* **Q: What should I do if I miss a dose?** A:  Contact your doctor or pharmacist for guidance on missed doses. Do not double up on doses.
* **Q: What are the long-term effects of Lorlatinib?** A:  Long-term effects can vary.  Regular monitoring is crucial to detect and manage potential side effects.
* **Q: Are there any drug interactions with Lorlatinib?** A: Yes, there are potential drug interactions. It is crucial to inform your doctor of all medications, supplements, and herbal remedies you are taking.
* **Q: How is the effectiveness of Lorlatinib monitored?** A:  Your doctor will use imaging tests (like CT scans) and blood tests to monitor the effectiveness of the treatment and to assess for side effects.


**Disclaimer:** This information is for educational purposes only and should not be considered medical advice.  Always consult with a qualified healthcare professional before starting any new medication or treatment. They can assess your individual needs and risks and provide personalized guidance.


**Note:** This information is AI-generated or crowd-sourced and may not be accurate. Please consult a medical professional for verified advice.